Magali VIDAL
University Hospital, Clermont-Ferrand
2
2
1
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Daniel Teupser, Prof.Dr.med.
Institute of Laboratory Medicine of the University Hospital of Munich
Shared therapeutic areas:
Patricia L Hibberd, MD, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Sanjay K Jain, MD
Johns Hopkins University
Shared therapeutic areas:
Heidi H Kong, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Shared therapeutic areas:
Michael Vogeser, Prof.Dr.med.
Institute of Laboratory Medicine of the University Hospital of Munich
Shared therapeutic areas:
Ulrikka Nygaard, Ass Prof PhD
Copenhagen University Hospital, Rigshospitalet
Shared therapeutic areas:
Yang Yan
First Affiliated Hospital Xi'an Jiaotong University
Shared therapeutic areas:
Thomas Tängdén, MD, Phd
Uppsala University Hospital
Shared therapeutic areas:
Mitsuharu Egawa
Meiji Seika Pharma Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)
All 2 trials loaded